10ÔÂ9ÈÕ£¬µÏ°²Õï¶ÏÆìÏÂÏþ·É¼ì½¡¿µÓëng28ÄϹ¬Öйú¡°Òø·¢Í¨¡±Æ½Ì¨Ç¿Ç¿ÁªºÏ£¬Æô¶¯°¢¶û´Äº£Ä¬²¡¾«×¼ÕïÁÆÏîÄ¿¡£Ë«·½½«ÒÔ¼¼ÊõÁ¢ÒìΪ»ùʯ£¬ÕûºÏ¸÷×ÔרҵÁ¦Á¿ºÍÓÅÊÆ×ÊÔ´£¬ÂòͨÏßÉÏÏßÏÂÇþµÀ£¬Í¨¹ýѪҺ±ê¼ÇÎï¼ì²âµÈÇ°Ñؼ¼ÊõÍƶ¯°¢¶û´Äº£Ä¬²¡£¨AD£©¡°ÔçɸºÍÔçÕ£¬µãÁÁÓ°ÏóÖ®¹â£¬ÊØ»¤¡°Òø·¢ÈËȺ¡±µÄ¸ßÖÊÁ¿½¡¿µÉú»î¡£
ÔÚÔ˶¯ÏÖ³¡£¬µÏ°²Õï¶Ï½¡¿µTo CÊÂÒµ²¿ÒµÎñ×ܼà³ÂÁ¢Æ½Óëng28ÄϹ¬ÖйúÒ©ÒµÉñ¾¿ÆѧÁìÓòÊÂÒµ±¾²¿Êг¡×ܼà³ÂÑ©´ú±íË«·½Ç©ÊðÁËÏîÄ¿ÏàÖúÐÒ飬µÏ°²Õï¶Ï¸±×ܲᢽ¡¿µTo CÊÂÒµ²¿×ܾÀíÍõÑåФºÍng28ÄϹ¬Öйú¸±×ܲá¢ng28ÄϹ¬ÖйúÒ©Òµ×ܾÀíÖÜÑóÏÖ³¡¼ûÖ¤ÁË´Ë´ÎÇ©Ô¼ÒÇʽ¡£
µÏ°²Õï¶Ï¸±×ܲᢽ¡¿µTo CÊÂÒµ²¿×ܾÀíÍõÑåФÖ´Ç
ÍõÑåФ½éÉÜÁ˵ϰ²Õï¶ÏÒµÎñÉú³¤Çé¿ö¼°Ïþ·É¼ì½¡¿µµÄÁ¢Òìģʽ¡£¡°ÎªÓ¦¶Ô°¢¶û´Äº£Ä¬²¡ÕâһȫÇò¹«¹²ÎÀÉúÌôÕ½£¬ÎÒÃÇÐ輯½áÉç»á¸÷½çÖ®Á¦£¬¹²Ïí×ÊÔ´£¬Ðͬ×÷Õ½¡£¡±ËýÌåÏÖ£¬´Ë´Î¾«×¼ÕïÁÆÏîÄ¿µÄÆô¶¯£¬±ê¼Ç×ÅË«·½½«ÔÚ°¢¶û´Äº£Ä¬²¡ÕïÁÆÁìÓòÉÏàÖú£¬½«×îÇ°Ñصļ¼ÊõÊÖ¶ÎÓ¦Óõ½°¢¶û´Äº£Ä¬²¡µÄ¾«×¼ÕïÁÆʵ¼ùÖУ¬ÎªÈ«¹úÄËÖÁÈ«ÇòµÄ°¢¶û´Äº£Ä¬²¡»¼ÕßÌṩ¸ü¾«×¼¡¢±ã½Ý¡¢¸ßЧµÄÒ½ÁÆЧÀÍ¡£
ng28ÄϹ¬Öйú¸±×ܲá¢ng28ÄϹ¬ÖйúÒ©Òµ×ܾÀíÖÜÑóÖ´Ç
ÖÜÑó½éÉÜÁËng28ÄϹ¬ÖйúÓ뾩¶«½¡¿µÅäºÏ´î½¨µÄÔÚÏß½¡¿µÐ§ÀÍƽ̨¡ª¡ªÒø·¢Í¨¡£ËûͬʱÌåÏÖ£¬¡°ÑªÒº¼ì²âÔÚ°¢¶û´Äº£Ä¬²¡ÖÎÁÆÁìÓòÖоßÓкÜÊÇÒªº¦µÄ¼ÛÖµ£¬²¢ÆÚ´ýÏþ·É¼ì½¡¿µÓëÒø·¢Í¨ÊµÏÖ×ÊÔ´¹²Ïí¡¢ÓÅÊÆ»¥²¹£¬ÂíÉÏÐж¯£¬ÅäºÏ¹¹½¨ÆðÁýÕÖ¡®Ô¤·À-ÔçɸÔç¼ì-ÖÎÁÆ-ºã¾ÃÖÎÀí¡¯È«Á÷³ÌµÄAD½¡¿µÖÎÀíÌåϵ£¬ÓÐЧÑÓ»º¼²²¡½ø³Ì£¬ÌáÉý»¼ÕßµÄÉú»îÆ·ÖÊ¡£¡±
µÏ°²Õï¶Ï½¡¿µTo CÊÂÒµ²¿ÒµÎñ×ܼà³ÂÁ¢Æ½½éÉÜÏîÄ¿¸Å¿ö
³ÂÁ¢Æ½ÌåÏÖ£¬¡°¸ÃÏîÄ¿Õë¶ÔÓÉ°¢¶û´Äº£Ä¬²¡ÒýÆðµÄÇá¶ÈÈÏÖªÕÏ°»¼Õß¼°°¢¶û´Äº£Ä¬²¡Çá¶È³Õ´ô»¼Õߣ¬Ìṩ°¢¶û´Äº£Ä¬²¡ÑªÒº¼ì²â£¬É¸Ñ¡ÔçÆÚ°¢¶û´Äº£Ä¬²¡»¼Õß½øÈëÁÙ´²¸ÉÔ¤ÖÎÁÆ¡£Ïþ·É¼ì½¡¿µµ÷¶¯Á˽ṹȫ¹ú145¸ö¶¼»áµÄ510¼Ò²ÉѪÍøµã£¬Óû§Ö»ÐèµÇ¼¡°Òø·¢Í¨¡±ÏßÉÏƽ̨ÎÊÕҽÉúÍƼö¼ì²â£¬Óû§ÖÁ²ÉѪµã²ÉÑù£¬µÏ°²ÊµÑéÊÒ³ö¾ßרҵ¼ì²â½á¹û£¬Óû§ÏßÉϼ´¿ÉÅÌÎʱ¨¸æ£¬Ê¹Óû§¡°×ã²»³ö»§¡±»ñµÃº¸ÇÔçɸ¡¢³õÕï¡¢ÓÃÒ©Ö¸µ¼ÔÚÄÚµÄһվʽЧÀÍ¡£
ng28ÄϹ¬ÖйúÉñ¾¿ÆѧÁìÓòÊÂÒµ±¾²¿ÖúÀíÊг¡¾Àí·ëÆäÀÖ·ÖÏí
·ëÆäÀÖÂÛÊöÁËÂØ¿¨Ä¹µÄ»ù±¾Çé¿ö£¬¸ÃÒ©Æ·ÊÇng28ÄϹ¬ÖйúÀÖ³ÉÒý½øµÄÊ׿î»ñÃÀ¹úʳƷҩƷ¼à¶½ÖÎÀí¾Ö£¨FDA£©ÍêÈ«Åú×¼ÓÃÓÚ°¢¶û´Äº£Ä¬²¡¡°¶ÔÒòÖÎÁÆ¡±µÄÒ©Îï¡£±ðµÄ£¬Ëû»¹·ÖÏíÁËÒø·¢Í¨Æ½Ì¨µÄ´´Á¢ÀíÄîºÍ¹¹½¨Àú³Ì¡£ËûÌåÏÖ£¬ng28ÄϹ¬Öйú½«Ó빤ҵÁ´ÉÏÏÂÓεÄÏàÖúͬ°éЯÊÖ£¬ÅäºÏ´òÔìÒ»¸öÁýÕÖ°¢¶û´Äº£Ä¬²¡¡°·À-ɸ-Õï-ÖÎ-»¤¡±È«Àú³ÌµÄÁ¢Òìר²¡·ÀÖÎÉú̬¡£
¿À³Æ×Ê×ϯ¿Æѧ¹ÙÎâÎÀ¼×²©Ê¿ÏÖ³¡·ÖÏí
ÎâÎÀ¼×²©Ê¿½éÉÜÁËÄ¿Ç°°¢¶û´Äº£Ä¬²¡µÄÖÖÖÖÕï¶ÏÒªÁ죬ÉîÈë½²½âÁ˼¸ÖÖÓÐÇ°¾°µÄѪ½¬ÉúÎï±ê¼ÇÎïÔÚÁÙ´²Ñо¿ÁìÓòµÄ×îж¯Ì¬£¬²¢ÌᵽѪҺA¦ÂÊÇÄ¿Ç°×î¾ßDZÔÚÓ¦ÓüÛÖµµÄADÉúÎï±ê¼ÇÎïÖ®Ò»¡£Ëû×ÅÖؽ²½âÁË¿À³Æ×ͨ¹ýISO15189ºÍCAPÁ½´óÖÊÁ¿ÌåϵÈÏÖ¤µÄÖÊÆ×ʵÑéÊÒÒý½øµÄ»ùÓÚIP-LC-MS/MS¼¼ÊõµÄQuest AD-Detect?¦Â-µí·ÛÑùÂÑ°×42/40ѪҺ¼ì²âÒªÁ죬ָ³öÃâÒß³ÁµíÖÊÆ×·¨£¨IP-MS£©ÔÚÖÚ¶àµÄÁÙ´²¼ìÑéÒªÁìѧÖÐÊÇÕï¶Ï׼ȷÐÔ×î¸ßµÄÁÙ´²ÒªÁ죬±»ÈÏΪÓëÄ¿Ç°ADÁÙ´²Õï¶ÏµÄ½ð±ê×¼Õýµç×Ó·¢Éä¶Ï²ãɨÃ裨PET£©×îΪ½Ó½ü[1] £¬Í¨¹ý¼ì²â¦Â-µí·ÛÑùÂÑ°×42/40£¬ÄÜΪADµÄ¾«×¼Ô¤·ÀºÍ¸ÉÔ¤£¬ÌṩÓë¹Å°åÄÔ¼¹Òº¼ì²âºÍPET³ÉÏñÒ»ÑùÓÐЧµÄÁÙ´²Ö§³Ö¡£
´Ë´ÎÏîÄ¿µÄÆô¶¯£¬±ê¼Ç×ŵϰ²Õï¶ÏÓëng28ÄϹ¬ÖйúÖ®¼äµÄÏàÖúͬ°é¹ØϵÂõ³öÁËÔ½·¢¼áʵµÄÒ»²½¡£Î´À´£¬Ë«·½½«³ä·ÖÀûÓø÷×ÔÔÚÒ½ÁÆÕï¶ÏºÍ¼²²¡ÖÎÁÆÁìÓòµÄר³¤£¬¾Û½¹Á½´ó½¹µãÄ¿±ê£ºÌáÉýÏȽøÕï¶Ï¼¼ÊõµÄÆÕ¼°Âʺ͹¹Öþ½¡È«Ð§ÀÍÌåϵ¡£ÔÚ´Ë»ù´¡ÉÏ£¬Ë«·½½«²»¾ø̽Ë÷¿ÆÑÐÏàÖúÐÂģʽÓë¼¼ÊõÁ¢Òì·¾¶£¬Éî¸û°¢¶û´Äº£Ä¬²¡ÔçÆÚɸ²é¼°»¼Õß¾ì×¢¼Æ»®£¬ÖúÁ¦ÊµÏÖ°¢¶û´Äº£Ä¬²¡Ô¤·ÀÓëÖÎÁƹؿÚÇ°Öã¬Ô츣¸ü¶à»¼Õß¼°Æä¼ÒÍ¥¡£
¹ØÓÚ¡°Òø·¢Í¨¡±
Òø·¢Í¨ÊǾ©ÒÃÎÀÏí£¨ÉϺ££©½¡¿µ¹¤ÒµÉú³¤ÓÐÏÞ¹«Ë¾µÄÏßÉÏÒµÎñ£¬¸Ã¹«Ë¾ÊÇng28ÄϹ¬ÖйúÓ뾩¶«½¡¿µµÄºÏ×ÊÆóÒµ¡£Òø·¢Í¨½ÓÄɱ±¾©¡¢ÉϺ£Ë«ÖÐÐÄģʽ£¬ÖÂÁ¦ÓÚΧÈÆ°¢¶û´Äº£Ä¬Ö¢¡°·À¡¢É¸¡¢Õï¡¢ÖΡ¢»¤¡±£¬Á¢Òì´´Á¢×¨²¡·ÀÖÎÉú̬£¬´òÔìÂú×ãÀÏÄêÓû§Éú»î½¡¿µÒ»Õ¾Ê½Ð§ÀÍƽ̨¡£×Ô2022ÄêÉÏÏßÒÔÀ´£¬ÒÑÓÐ5600ÓàÃû¼²²¡¸ßÏà¹Ø¿ÆÊÒÒ½ÉúÈëפ£¬²¢Í¨¹ýÊìÒ½»¼Ä£Ê½£¬Ð§ÀÍ17Íò¾«×¼»¼Õß¼°Æä¼ÒÊô£¬ÒѳÉΪº£ÄÚ¾ßÓÐ×î¶à¡¢×׼AD»¼ÕßȺÌåµÄƽ̨֮һ¡£
¹ØÓÚ¡°Ïþ·É¼ì½¡¿µ¡±
Ïþ·É¼ì½¡¿µÊǵϰ²Õï¶ÏÖصã´òÔìµÄÃæÏòC¶ËµÄÒ½ÁÆЧÀÍ×ÓÆ·ÅÆ£¬ÒÀÍÐÁ¬Ëø»¯Ò½Ñ§ÊµÑéÊÒºÍÊýÖÇ»¯ÊֶΣ¬½«Ò½Ôº¼ìÑé¿ÆÍêÕûµØ°áµ½ÏßÉÏ¡£Ïþ·É¼ìÌṩרҵ±ã½ÝµÄ¾Ó¼Ò²ÉÑùºÍÉçÇø²ÉѪµãЧÀÍ£¬Í¨¹ý´î½¨¹«Á¢Ò½Ôº½¡¿µÖÎÀí£¨Ìå¼ì£©ÁªºÏÌåO2Oƽ̨£¬Ó빫Á¢Ò½ÔºÒ»Í¬ÎªÓû§Ìṩ¸üΪ¸öÐÔ»¯µÄ½¡¿µÖÎÀíЧÀÍ£¬ÊµÏÖ¡°Ò½Ñ§Õï¶Ï²»³öÁÚÀµÄʹÃü¡£
²Î¿¼ÎÄÏ×£º
[1] The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer¡¯s disease: a literature review. Brand et al. Alzheimer¡¯s Research & Therapy (2022) 14:195